Ditchcarbon
  • Customers
  1. Organizations
  2. Kedrion
Public Profile
Pharmaceutical Preparation Manufacturing
IT
updated 10 days ago

Kedrion

Company website

Kedrion Biopharma, commonly referred to as Kedrion, is a leading global player in the biopharmaceutical industry, headquartered in Italy. Founded in 2001, the company has established a strong presence in major operational regions, including Europe and North America, focusing on the development and production of human plasma-derived therapies. Kedrion's core offerings include immunoglobulins, clotting factors, and albumin, which are essential for treating various medical conditions. What sets Kedrion apart is its commitment to quality and innovation, ensuring that its products meet the highest safety standards. With a robust market position, Kedrion has achieved significant milestones, including expanding its product portfolio and enhancing its global distribution network, solidifying its reputation as a trusted provider in the biopharmaceutical sector.

DitchCarbon Score

How does Kedrion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Kedrion's score of 27 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.

51%

Let us know if this data was useful to you

Kedrion's reported carbon emissions

In 2022, Kedrion reported total carbon emissions of approximately 30,122,000 kg CO2e from Scope 1 and about 35,982,000 kg CO2e from Scope 2. This represents a significant increase in emissions compared to 2021, where Scope 1 emissions were about 16,894,000 kg CO2e and Scope 2 emissions were approximately 25,581,000 kg CO2e. The data indicates a trend of rising emissions over the years, with 2020 figures showing Scope 1 emissions at about 32,736,000 kg CO2e and Scope 2 at around 21,143,000 kg CO2e. Kedrion's emissions data is cascaded from its parent company, Kedrion S.p.A., reflecting its current subsidiary status. However, there are no specific reduction targets or climate pledges documented for Kedrion, nor are there any reported initiatives under the Science Based Targets initiative (SBTi) or other climate frameworks. The absence of Scope 3 emissions data suggests a potential area for future reporting and improvement. Overall, while Kedrion has made strides in emissions reporting, the lack of reduction commitments highlights an opportunity for enhanced climate action and transparency in their sustainability efforts.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2019202020212022
Scope 1
2,421
00,000,000
00,000,000
00,000,000
Scope 2
21
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Kedrion's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Kedrion is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Kedrion is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Grifols

ES
•
Pharmaceutical Preparation Manufacturing
Updated about 15 hours ago

Shire plc

IE
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

CSL Behring N.V.

BE
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Itron

US
•
Research and development services (73)
Updated 4 days ago

ADMA Biologics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Biotest

DE
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy